Hutch News
Results per Page:
Examining factors that may impact ovarian cancer survival disparities
From the Harris Group, Public Health Sciences Division
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
Genital powder use and epithelial ovarian cancer
From the Harris Group, Division of Public Health Sciences
Tip Sheet: Disparities in cancer outcomes, catching up on cancer screenings, boosting immunotherapy effectiveness and SARS-CoV-2 origins
Summaries of recent Fred Hutch research findings and other news
Fred Hutch announces recipients of inaugural diversity, equity and inclusion awards
Awards recognize employees who have shown outstanding commitment to Fred Hutch’s diversity, equity and inclusion efforts
Bringing science and better health outcomes to all
Fred Hutch’s Pathways to Equity Symposium: Heartbreaking statistics, hopeful plans, and recognition for a pair of health-equity trailblazers
Advances in blood disorders research continue despite COVID-19
Expanding use of CAR T-cell therapies, gene editing lead to insights at virtual annual meeting of the American Society of Hematology
Fred Hutch joins Washington Employers for Racial Equity
New coalition includes over 50 companies and organizations across the state
'It is time to call out structural racism in medicine and work fervently to dismantle it'
Dr. Rachel Issaka shares personal experiences with racism, calls on medical field to take antiracist action
Racial disparities in endoscopy wait-time and stage at diagnosis
From the Issaka Group, Division of Public Health Sciences
Health disparities may affect end-of-life experiences of minority blood cancer patients
A new study finds ethnic and racial minorities with leukemia or lymphoma are more likely to die in hospital, receive aggressive care in last weeks of life than white patients
Socioeconomic factors behind breast cancer disparities
From the Li Lab, Public Health Sciences Division.
Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the United States
Study examined trends in advanced breast, colon and prostate cancers from 1992-2004